Cartesian Therapeutics (RNAC)

• Market cap: $254M
• 1 day: 6%
• 5 days: 39.29%
• 1 month: 40.65%
• 3 months: 33.08%
• 6 months: 19.48%
• Year to date: 27.96%
• 1 year: -16.99%
• 5 years: -89.78%
• 10 years: -97.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

Employees: 75